Dr. Renuka V. Iyer, MD
- Medicare services, 2024
- 212
- Medicare patients, 2024
- 116
- Part D claims, 2024
- 121
- Publications
- 92
- Clinical trials
- 10
- Practice address
- 344 S Hauser Blvd, Los Angeles, CA 90036
- Practice phone
- Call (716) 845-2300
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Roswell Park Cancer Institute
Los Angeles, California
Find Dr. Iyer's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Renuka V. Iyer is a medical oncologist in Los Angeles, California
Dr. Iyer practices at Roswell Park Cancer Institute in Los Angeles, California.
Dr. Iyer's NPI, 1891792982, was assigned on July 5, 2005. Dr. Iyer holds New York license 221676.
- NPI
- 1891792982NPI Registry (opens in a new tab)
- Medicare PAC ID
- 4183601818
- NPI enumeration date
- July 5, 2005
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (716) 845-2300
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 57
- Medical school graduation
- 1995
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Renuka V. Iyer practices at Roswell Park Cancer Institute in Los Angeles, California
Dr. Iyer's primary practice is Roswell Park Cancer Institute, at 344 S Hauser Blvd, Los Angeles, CA 90036 in Los Angeles County. The practice phone is (716) 845-2300.
- Roswell Park Cancer Institute344 S Hauser Blvd, Los Angeles, CA 90036 · Los Angeles CountyPhone(716) 845-2300
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Renuka V. Iyer is affiliated with 2 sites of care and 1 medical group
Dr. Iyer's primary practice is Roswell Park Cancer Institute in Los Angeles, California. Dr. Iyer is also affiliated with Roswell Park Comprehensive Cancer Center. The medical group on file is Roswell Park Comprehensive Cancer Center.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Renuka V. Iyer's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Iyer practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Roswell Park Cancer Institute | Available with a free account |
| +1 more affiliated site | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Renuka V. Iyer is one of 415 medical oncologists in California
Medical oncology is Dr. Iyer's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Iyer is licensed in New York.
Specialties and state licenses
- Medical oncology, New YorkPrimary
Medical oncologists near Dr. Iyer
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Renuka V. Iyer billed Medicare for 212 services in 2024
CMS data shows 212 Medicare services from Dr. Iyer across 3 procedure codes in 2024, all of them office visits, for 116 Medicare patients. Medicare paid $18,597 for them. Every service was in a facility, such as a hospital, rather than an office.
Dr. Iyer's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 1942024: 2129%
Dr. Iyer compared with the California median for medical oncologists, 2024
- Dr. Iyer
- California median
- Medicare services
- 212vs 49657% below
- Medicare patients
- 116vs 15425% below
- Part D claims
- 22vs 14485% below
Medians across 358 medical oncologists in California with Dmand AI profiles that report each measure.
Dr. Iyer's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Iyer?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Iyer and other medical oncologists in California.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Renuka V. Iyer treated 116 Medicare patients in 2024, average age 72
CMS counts 116 Medicare patients who saw Dr. Iyer in 2024. The largest group is 65 to 74, with 56 patients. 75% of them have high blood pressure, and 74% have high cholesterol. Their average risk score is 3.19, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Iyer's median patient age at 71, with 50% women.
Dr. Iyer's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Iyer's Medicare patients by sex, 2024
- Women6052%
- Men5648%
Chronic conditions among Dr. Iyer's Medicare patients, 2024
- High blood pressure75%
- High cholesterol74%
- Arthritis39%
- Cancer34%
- Diabetes34%
- Chronic kidney disease29%
- Ischemic heart disease27%
- Anxiety24%
Share of Medicare patients with each condition. A patient can have several.
Dr. Iyer's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 71
Patient panel by sex, all payers
- Women50%
- Men49%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Renuka V. Iyer wrote 121 Medicare Part D claims in 2024
In 2024, Dr. Iyer wrote 121 Medicare Part D claims for 47 patients. 61% of them were for generic drugs. CMS names the drug for 22 of them, across 1 drug with 11 or more claims each, at $50,053 in total drug cost. In 2023, CMS named 18 claims across 1 drug.
Dr. Iyer's Part D claims by kind of drug, 2024
- Generic74 claims61%
- Brand-name47 claims39%
Dr. Iyer's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 182024: 2222%
Drugs named by CMS: 1 in 2024, 1 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Renuka V. Iyer offers telehealth to Medicare patients
Dr. Iyer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Iyer as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Renuka V. Iyer has 92 publications on record
Dmand AI links 92 papers to Dr. Iyer, published from 2005 to 2025. 2020 was the busiest year, with 9. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Pancreatic Neoplasms and Carcinoma, Hepatocellular. Dr. Iyer has published most often in Cancers (Basel). Dr. Iyer's most frequent co-authors are Sarbajit Mukherjee, Patrick M. Boland, MD and Christos Fountzilas, MD.
Dr. Iyer's papers by year, 2016 to 2025
Topics Dr. Iyer writes about most
- Antineoplastic Combined Chemotherapy Protocols
- Pancreatic Neoplasms
- Carcinoma, Hepatocellular
- Liver Neoplasms
- Neuroendocrine Tumors
- Stomach Neoplasms
- Deoxycytidine
- Gemcitabine
Dr. Iyer's most frequent co-authors
- Sarbajit Mukherjee13 shared papers
- Patrick M. Boland, MD4 shared papers
- Christos Fountzilas, MD4 shared papers
Recent publications by Dr. Iyer
See who Dr. Iyer researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Iyer works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Renuka V. Iyer has worked on 10 clinical trials
Dmand AI links Dr. Iyer to 10 clinical trials, 6 of them phase 2 studies. 6 are still active or recruiting. Conditions studied include Carcinoma, Hepatocellular, Gallbladder Neoplasms and Gallbladder Diseases. National Cancer Institute (NCI) sponsors the most, 5.
Clinical trials with Dr. Iyer by phase
- NonePhase 1: no trials
- 1Phase 1/2: 1 trial
- 6Phase 2: 6 trials
- 2Phase 3: 2 trials
- NonePhase 4: no trials
Conditions in Dr. Iyer's trials
- Carcinoma, Hepatocellular
- Gallbladder Neoplasms
- Gallbladder Diseases
- Liver Neoplasms
- Carcinoma, Neuroendocrine
Investigators on the most trials with Dr. Iyer
- Hassan Hatoum, MD4 shared trials
- Kathryn Cunningham Hourdequin, MD4 shared trials
- Daneng Li, MD4 shared trials
Recent clinical trials with Dr. Iyer
A Phase Ib/ II Study of Sorafenib and Pembrolizumab in Advanced Hepatocellular Cancer (HCC) (opens in a new tab)
A Randomized Phase 2 Study of Combination Atezolizumab and CDX-1127 (Varlilumab) With or Without Addition of Cobimetinib in Previously Treated Unresectable Biliary Tract Cancers (opens in a new tab)
An Expanded Access Program of Surufatinib for Patients With Advanced or Metastatic Neuroendocrine Tumors (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Renuka V. Iyer received $147,153 in industry payments from 2016 to 2025
CMS Open Payments shows 187 general payments to Dr. Iyer from 22 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 80% of the total. AstraZeneca Pharmaceuticals LP paid the most, $32,524.
General payments to Dr. Iyer by program year, 2016 to 2025
General payments to Dr. Iyer by kind, 2016 to 2025
- Consulting fees$117,14280%
- Travel and lodging$9,6367%
- Speaker and faculty fees$7,9205%
- Food and beverage$7,0365%
- Other$5,3774%
Companies that paid Dr. Iyer the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Renuka V. Iyer's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Renuka V. Iyer
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Renuka V. Iyer's NPI number?
Dr. Renuka V. Iyer's NPI number is 1891792982. It was assigned on July 5, 2005, and it is active in the NPI Registry.
What kind of doctor is Dr. Renuka V. Iyer?
Dr. Renuka V. Iyer is a medical oncologist in Los Angeles, California. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Renuka V. Iyer practice?
Dr. Iyer practices at 344 S Hauser Blvd, Los Angeles, CA 90036. Dr. Iyer's primary practice is Roswell Park Cancer Institute in Los Angeles, California.
What is Dr. Renuka V. Iyer's office phone number?
The practice phone on file for Dr. Iyer is (716) 845-2300.
What is Dr. Renuka V. Iyer's medical license number?
Dr. Iyer holds New York license 221676.
Which hospitals is Dr. Renuka V. Iyer affiliated with?
Dr. Iyer is affiliated with Roswell Park Comprehensive Cancer Center.
What medical group is Dr. Renuka V. Iyer part of?
Dr. Iyer is linked to Roswell Park Comprehensive Cancer Center.
Does Dr. Renuka V. Iyer accept Medicare?
Yes. CMS data shows Dr. Iyer billed Medicare for 212 services in 2024, and Dr. Iyer accepts Medicare assignment.
Does Dr. Renuka V. Iyer offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Iyer as offering telehealth services.
How many Medicare patients does Dr. Renuka V. Iyer see?
CMS counts 116 Medicare patients who saw Dr. Iyer in 2024, with an average age of 72.
Show 6 more questionsShow fewer questions
What services does Dr. Renuka V. Iyer bill to Medicare?
In 2024, Dr. Iyer's most billed Medicare services were office visit, established patient (99214), office visit, established patient (99215) and office visit, new patient (99205).
What drugs does Dr. Renuka V. Iyer prescribe most?
In 2024 Medicare Part D data, Dr. Iyer's most prescribed drugs by claims were Creon.
Has Dr. Renuka V. Iyer received payments from drug or device companies?
CMS Open Payments shows $147,153 in general payments to Dr. Iyer from 22 companies from 2016 to 2025. The largest total came from AstraZeneca Pharmaceuticals LP.
How long has Dr. Renuka V. Iyer been practicing?
Dr. Iyer graduated from medical school in 1995, 31 years ago.
Does Dr. Renuka V. Iyer do research?
Dmand AI links 92 publications to Dr. Iyer, published from 2005 to 2025. Dr. Iyer has worked on 10 clinical trials.
Who does Dr. Renuka V. Iyer publish with?
Dr. Iyer's most frequent co-authors are Sarbajit Mukherjee (13 shared papers), Patrick M. Boland, MD (4 shared papers) and Christos Fountzilas, MD (4 shared papers).
Selling to medical oncology practices?
See medical oncologists in California by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card